LePu Biopharma Co., Ltd.
Clinical trials sponsored by LePu Biopharma Co., Ltd., explained in plain language.
A biopharmaceutical company focused on drugs for cardiovascular and metabolic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for pancreatic cancer: experimental drug MRG004A enters final testing phase Results expected Jun 2027 (estimated)
- Can a drug duo shrink Hard-to-Treat tumors? Results expected Aug 2027 (estimated)